EXPRESSION OF PRO AND ANTIINFLAMMATORY CYTOKINES DURING ANTIPCSK9 THERAPY IN PATIENTS WITH STATIN RESISTANT FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Suarez-Cuenca, Juan Antonio [1 ]
Morales Portano, Julieta [1 ]
Bricia Margarita, Roa-Martinez [1 ]
De Vaca Rebeca, Perez-Cabeza [1 ]
Rafael, Trujillo-Cortes [1 ]
机构：
[1] Ctr Med Nacl 20 Noviembre ISSSTE, Mexico City, DF, Mexico
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1545-144
引用
收藏
页码：1347 / 1347
页数：1
相关论文
共 50 条
  • [1] EXPRESSION OF PRO AND ANTI-INFLAMMATORY CYTOKINES DURING ANTI-PCSK9 THERAPY IN PATIENTS WITH STATIN RESISTANT FAMILIAL HYPERCHOLESTEROLEMIA
    Suarez-Cuenca, Juan
    Morales-Portano, Julieta
    Roa-Martinez, Bricia
    Trujillo-Cortes, Rafael
    ATHEROSCLEROSIS, 2024, 395
  • [2] Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia
    Morales-Portano, Julieta Danira
    Trujillo-Cortes, Rafael
    Roa-Martinez, Bricia Margarita
    de Vaca, Rebeca Perez-Cabeza
    Garcia, Silvia
    Mondragon-Teran, Paul
    Suarez-Cuenca, Juan A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [3] Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia
    Braamskamp, Marjet J. A. M.
    Kastelein, John J. P.
    Kusters, D. Meeike
    Hutten, Barbara A.
    Wiegman, Albert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (04) : 455 - 456
  • [4] Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia
    Korneva, Viktoria
    Kuznetsova, Tatiana
    Julius, Ulrich
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 79 - 87
  • [5] Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia
    Skoumas, John
    Liontou, Catherine
    Chrysohoou, Christina
    Masoura, Constantina
    Aznaouridis, Konstantinos
    Pitsavos, Christos
    Stefanadis, Christodoulos
    ATHEROSCLEROSIS, 2014, 237 (01) : 140 - 145
  • [6] Genetic and environmental factors affecting the response to statin therapy in patients with familial hypercholesterolemia
    Miltiadous, G
    Xenophontos, S
    Bairaktari, E
    Tsimixodimos, V
    Kalogirou, M
    Cariolou, M
    Elisaf, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 139 - 139
  • [7] High-Dose Statin Therapy Does Not Induce Insulin Resistance in Patients with Familial Hypercholesterolemia
    Panz, Vanessa
    Immelman, Andrew
    Paiker, Janice
    Pilcher, Gillian
    Raal, Frederick
    METABOLIC SYNDROME AND RELATED DISORDERS, 2012, 10 (05) : 351 - 357
  • [8] Effect of Statin Therapy in Tpe-Interval and Tpe/Qtc Ratio in Patients with Familial Hypercholesterolemia
    Kucukosmanoglu, Mehmet
    Kilic, Salih
    Saracoglu, Erhan
    Cekici, Yusuf
    Vuruskan, Ertan
    Kayikcioglu, Meral
    EUROPEAN JOURNAL OF THERAPEUTICS, 2020, 26 (03): : 165 - 171
  • [9] Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High-Dose Statin Therapy
    Raal, Frederick
    Panz, Vanessa
    Immelman, Andrew
    Pilcher, Gillian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02):
  • [10] Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia
    van Tits, LJH
    van Himbergen, TM
    Lemmers, HLM
    de Graaf, J
    Stalenhoef, AFH
    ATHEROSCLEROSIS, 2006, 185 (02) : 307 - 312
12345